Michelle Robertson
Overview
Michelle Robertson received an average of $3M in total compensation, including $402K in salary, at Editas Medicine between 2020 and 2021. Michelle Robertson also received an average of $1M at Momenta Pharmaceuticals between 2018 and 2019.
Source: SEC filings on April 26, 2022, April 20, 2021, April 24, 2020, and April 26, 2019.
Related executives
We found 28 more executives who work or worked at Editas Medicine and Momenta Pharmaceuticals.
James Mullen
Editas Medicine
Chief Executive Officer
Mark Shearman
Editas Medicine
Chief Scientific Officer
Bruce Eaton
Editas Medicine
Executive Vice President and Chief Business Officer
Lisa Michaels
Editas Medicine
Chief Medical Officer
Cynthia Collins
Editas Medicine
Chief Executive Officer
Charles Albright
Editas Medicine
Chief Scientific Officer
Judith Abrams
Editas Medicine
Chief Medical Officer
Eric Ek
Editas Medicine
Chief Financial Officer
News
Editas Medicine CEO James Mullen's 2021 pay jumps 354% to $6.7M
April 26, 2022
Editas Medicine CFO Michelle Robertson's 2020 pay jumps 266% to $3.6M
April 20, 2021
Momenta Pharmaceuticals CEO Craig Wheeler's 2019 pay stays at $4.6M
April 24, 2020
Momenta Pharmaceuticals CEO Craig Wheeler's 2018 pay slips 4% to $4.6M
April 26, 2019